In a patient with chronic liver disease undergoing large‑volume paracentesis, is any injection other than albumin required?

Albumin is the Only Required Injection After Large-Volume Paracentesis

For large-volume paracentesis (>5 L), albumin infusion at 6-8 g per liter of ascites removed is the only injection required and strongly recommended. No other injections are necessary or recommended in routine practice 1.

The Evidence Base

The 2021 Gut guidelines provide high-quality evidence with a strong recommendation that albumin (20% or 25% solution) should be infused after paracentesis of >5 L at a dose of 8 g albumin/L of ascites removed 1. This is the most recent, highest-quality guideline evidence available and should guide practice.

Why Albumin Specifically?

Albumin prevents post-paracentesis circulatory dysfunction (PPCD), which occurs when large-volume fluid removal causes:

• Reduced systemic vascular resistance
• Activation of renin-angiotensin and sympathetic systems
• Risk of kidney injury, electrolyte imbalances, hepatic encephalopathy, and death 2

Albumin reduces the odds of PPCD by 61% (OR = 0.39,95% CI 0.27-0.55) compared to alternative treatments, and also reduces hyponatremia by 42% and mortality by 36% 3.

What About Alternative Plasma Expanders?

While synthetic plasma expanders (dextran 70, hydroxyethyl starch, gelofusine) have been studied, albumin is superior:

• Alternative expanders cause significantly greater activation of the renin-angiotensin-aldosterone system 4
• Hydroxyethyl starch can fill Kupffer cells and cause portal hypertension 5
• Meta-analyses show albumin is more effective in preventing hyponatremia (8% vs 17% for other expanders) 4
• The 2021 guidelines explicitly recommend albumin over alternatives based on this evidence 1

Dosing Algorithm

For paracentesis >5 L:

• Administer 20% or 25% albumin solution
• Dose: 6-8 g per liter of ascites removed
• Example: 8 L removed = 48-64 g albumin (approximately 200-250 mL of 25% solution)
• Infuse after paracentesis is completed 1, 6

For paracentesis <5 L:

• Albumin can be considered (not mandatory) in patients with:
  • Acute-on-chronic liver failure (ACLF)
  • High risk of post-paracentesis acute kidney injury
  • Hypotension, renal insufficiency, or electrolyte abnormalities 1, 2

Important Caveats

Risk increases with >8 L removal: The risk of PPCD increases when >8 L of fluid is evacuated in a single session. Consider limiting paracentesis to <8 L per session or using higher albumin doses (9 g/L) if larger volumes are necessary 6.

Volume overload risk: In patients with cardiac dysfunction or severe portal hypertension, infuse albumin slowly to prevent cardiac overload. These patients may have coexisting cardiomyopathy 3.

Not a substitute for definitive therapy: Patients requiring repeated large-volume paracentesis should be evaluated for TIPS or liver transplantation, as 21% die within 6 months of becoming refractory to medical therapy 5.

What About Other Injections?

Blood products are NOT recommended: Routine measurement of PT/INR and platelet count before paracentesis and prophylactic transfusion of blood products are not recommended (moderate quality evidence, strong recommendation) 1.

Midodrine is NOT equivalent: While one recent study suggested oral midodrine might prevent PPCD in ACLF patients with 3-5 L paracentesis 7, this is a single small trial and not supported by guidelines. The 2021 Gut guidelines only mention midodrine as a weak recommendation for refractory ascites management on a case-by-case basis, not as a replacement for albumin 1.